NTEC - Intec Pharma Ltd.

NasdaqCM - NasdaqCM Real Time Price. Currency in USD

Intec Pharma Ltd.

RMPE building
12 Hartom Street Har Hotzvim PO Box 45219
Jerusalem 9777512
Israel
972 2 586 4657
http://www.intecpharma.com

SectorHealthcare
IndustryBiotechnology
Full Time Employees70

Key Executives

NameTitlePayExercisedYear Born
Mr. Jeffrey A. MecklerVice Chairman & CEO761.75kN/A1967
Mr. Nir SassiChief Financial Officer293.96kN/A1976
Dr. Nadav Navon Ph.D.Chief Operating Officer355.77kN/A1969
Mr. Walt Addison LinscottChief Bus. Officer478.61kN/A1961
Dr. R. Michael GendreauChief Medical Officer473.57kN/A1956
Amounts are as of December 31, 2018 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

Intec Pharma Ltd., a clinical stage biopharmaceutical company, focuses on developing drugs based on its proprietary Accordion Pill platform technology in Israel. Its Accordion Pill is an oral drug delivery system that is designed to enhance the efficacy and safety of existing drugs and drugs in development by utilizing a gastric retention and specific release mechanism. The company's lead product candidate is Accordion Pill Carbidopa/Levodopa, which is in a Phase III clinical trial for the treatment of Parkinson's disease symptoms in advanced Parkinson's disease patients. It is also developing Accordion Pill Zaleplon that is in a Phase III clinical trial as a treatment for the induction and maintenance of sleep in patients suffering from insomnia; a product candidate, which has completed a Phase I clinical trial for the prevention and treatment of gastroduodenal and small bowel Nonsteroidal Anti-Inflammatory Drug induced ulcers; and AP-CBD/THC, AP-THC, and AP-CBD product candidates with Cannabidiol and 9-Tetrahydrocannabinol for the treatment of various indications, including low back pain, neuropathic pain, and fibromyalgia. Intec Pharma Ltd. has a research collaboration agreement with Merck to explore using the Accordion Pill platform for development program. The company was formerly known as Intec Pharmaceuticals (2000) Ltd. and changed its name to Intec Pharma Ltd. in March 2004. Intec Pharma Ltd. was founded in 2000 and is based in Jerusalem, Israel.

Corporate Governance

Intec Pharma Ltd.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.